Results
|
|
81.
|
Dual EGFR inhibition in combination with anti-VEGF treatment: a phase I clinical trial in non-small cell lung cancer. [electronic resource] by
- Falchook, Gerald S
- Naing, Aung
- Hong, David S
- Zinner, Ralph
- Fu, Siqing
- Piha-Paul, Sarina A
- Tsimberidou, Apostolia M
- Morgan-Linnell, Sonia K
- Jiang, Yunfang
- Bastida, Christel
- Wheler, Jennifer J
- Kurzrock, Razelle
Producer: 20130829
In:
Oncotarget vol. 4
Availability: No items available.
|
|
|
82.
|
Phase I clinical trial of lenalidomide in combination with sorafenib in patients with advanced cancer. [electronic resource] by
- Ganesan, Prasanth
- Piha-Paul, Sarina
- Naing, Aung
- Falchook, Gerald
- Wheler, Jennifer
- Fu, Siqing
- Hong, David S
- Kurzrock, Razelle
- Janku, Filip
- Laday, Shell
- Bedikian, Agop Y
- Kies, Merrill
- Wolff, Robert A
- Tsimberidou, Apostolia M
Producer: 20141112
In:
Investigational new drugs vol. 32
Availability: No items available.
|
|
|
83.
|
Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver. [electronic resource] by
- Said, Rabih
- Kurzrock, Razelle
- Naing, Aung
- Hong, David S
- Fu, Siqing
- Piha-Paul, Sarina A
- Wheler, Jennifer J
- Janku, Filip
- Kee, Bryan K
- Bidyasar, Savita
- Lim, Joann
- Wallace, Michael
- Tsimberidou, Apostolia M
Producer: 20160512
In:
Investigational new drugs vol. 33
Availability: No items available.
|
|
|
84.
|
Phase 1 Dose Escalation Study of the Allosteric AKT Inhibitor BAY 1125976 in Advanced Solid Cancer-Lack of Association between Activating AKT Mutation and AKT Inhibition-Derived Efficacy. [electronic resource] by
- Schneeweiss, Andreas
- Hess, Dagmar
- Joerger, Markus
- Varga, Andrea
- Moulder, Stacy
- Tsimberidou, Apostolia M
- Ma, Cynthia
- Hurvitz, Sara A
- Rentzsch, Christine
- Rudolph, Marion
- Thiele, Silke
- Boix, Oliver
- Wilkinson, Gary
- Lagkadinou, Eleni
- Ocker, Matthias
Publication details: Cancers Dec 2019
In:
Cancers vol. 11
Availability: No items available.
|
|
|
85.
|
MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study. [electronic resource] by
- Hong, David S
- Hui, David
- Bruera, Eduardo
- Janku, Filip
- Naing, Aung
- Falchook, Gerald S
- Piha-Paul, Sarina
- Wheler, Jennifer J
- Fu, Siqing
- Tsimberidou, Apostolia M
- Stecher, Michael
- Mohanty, Prasant
- Simard, John
- Kurzrock, Razelle
Producer: 20140623
In:
The Lancet. Oncology vol. 15
Availability: No items available.
|
|
|
86.
|
Dual EGFR blockade with cetuximab and erlotinib combined with anti-VEGF antibody bevacizumab in advanced solid tumors: a phase 1 dose escalation triplet combination trial. [electronic resource] by
- Subbiah, Vivek
- Dumbrava, Ecaterina Ileana
- Jiang, Yunfang
- Thein, Kyaw Z
- Naing, Aung
- Hong, David S
- Fu, Siqing
- Piha-Paul, Sarina A
- Tsimberidou, Apostolia M
- Janku, Filip
- Meric-Bernstam, Funda
- Kurzrock, Razelle
- Falchook, Gerald
Publication details: Experimental hematology & oncology 2020
In:
Experimental hematology & oncology vol. 9
Availability: No items available.
|
|
|
87.
|
Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic. [electronic resource] by
- Dembla, Vikas
- Somaiah, Neeta
- Barata, Pedro
- Hess, Kenneth
- Fu, Siqing
- Janku, Filip
- Karp, Daniel D
- Naing, Aung
- Piha-Paul, Sarina Anne
- Subbiah, Vivek
- Tsimberidou, Apostolia M
- Shaw, Kenna
- Meric-Bernstam, Funda
- Hong, David S
Publication details: Oncotarget Sep 2018
In:
Oncotarget vol. 9
Availability: No items available.
|
|
|
88.
|
Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma. [electronic resource] by
- Tsimberidou, Apostolia M
- McLaughlin, Peter
- Younes, Anas
- Rodriguez, Maria A
- Hagemeister, Fredrick B
- Sarris, Andreas
- Romaguera, Jorge
- Hess, Mark
- Smith, Terry L
- Yang, Ying
- Ayala, Ana
- Preti, Alejandro
- Lee, Ming-Sheng
- Cabanillas, Fernando
Producer: 20030128
In:
Blood vol. 100
Availability: No items available.
|
|
|
89.
|
Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors. [electronic resource] by
- Falchook, Gerald S
- Wheler, Jennifer J
- Naing, Aung
- Piha-Paul, Sarina A
- Fu, Siqing
- Tsimberidou, Apostolia M
- Hong, David S
- Janku, Filip
- Zinner, Ralph
- Jiang, Yunfang
- Huang, Mei
- Lin, Quan
- Parkhurst, Kristin
- Kurzrock, Razelle
Producer: 20150918
In:
Investigational new drugs vol. 33
Availability: No items available.
|
|
|
90.
|
Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trials. [electronic resource] by
- Subbiah, Ishwaria M
- Falchook, Gerald S
- Kaseb, Ahmed O
- Hess, Kenneth R
- Tsimberidou, Apostolia M
- Fu, Siqing
- Subbiah, Vivek
- Hong, David S
- Naing, Aung
- Piha-Paul, Sarina A
- Akmal, Owais
- Janku, Filip
- Kurzrock, Razelle
Producer: 20160802
In:
Oncotarget vol. 6
Availability: No items available.
|
|
|
91.
|
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia. [electronic resource] by
- Tsimberidou, Apostolia M
- Kantarjian, Hagop M
- Cortes, Jorge
- Thomas, Deborah A
- Faderl, Stefan
- Garcia-Manero, Guillermo
- Verstovsek, Srdan
- Ferrajoli, Alessandra
- Wierda, William
- Alvarado, Yesid
- O'Brien, Susan M
- Albitar, Maher
- Keating, Michael J
- Giles, Francis J
Producer: 20030416
In:
Cancer vol. 97
Availability: No items available.
|
|
|
92.
|
Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies. [electronic resource] by
- Wang, Yudong
- Janku, Filip
- Piha-Paul, Sarina
- Hess, Kenneth
- Broaddus, Russell
- Liu, Lidong
- Shi, Naiyi
- Overman, Michael
- Kopetz, Scott
- Subbiah, Vivek
- Naing, Aung
- Hong, David
- Tsimberidou, Apostolia M
- Karp, Daniel
- Yao, James
- Fu, Siqing
Producer: 20201112
In:
Scientific reports vol. 10
Availability: No items available.
|
|
|
93.
|
A phase I trial of combination trastuzumab, lapatinib, and bevacizumab in patients with advanced cancer. [electronic resource] by
- Falchook, Gerald S
- Moulder, Stacy
- Naing, Aung
- Wheler, Jennifer J
- Hong, David S
- Piha-Paul, Sarina A
- Tsimberidou, Apostolia M
- Fu, Siqing
- Zinner, Ralph
- Janku, Filip
- Jiang, Yunfang
- Huang, Mei
- Parkhurst, Kristin L
- Kurzrock, Razelle
Producer: 20150918
In:
Investigational new drugs vol. 33
Availability: No items available.
|
|
|
94.
|
Phase I Dose-Escalation Study of Anti-CTLA-4 Antibody Ipilimumab and Lenalidomide in Patients with Advanced Cancers. [electronic resource] by
- Sakamuri, Divya
- Glitza, Isabella C
- Betancourt Cuellar, Sonia L
- Subbiah, Vivek
- Fu, Siqing
- Tsimberidou, Apostolia M
- Wheler, Jennifer J
- Hong, David S
- Naing, Aung
- Falchook, Gerald S
- Fanale, Michelle A
- Cabanillas, Maria E
- Janku, Filip
Producer: 20190409
In:
Molecular cancer therapeutics vol. 17
Availability: No items available.
|
|
|
95.
|
Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center. [electronic resource] by
- Liu, Qi
- Fayad, Luis
- Cabanillas, Fernando
- Hagemeister, Fredrick B
- Ayers, Gregory D
- Hess, Mark
- Romaguera, Jorge
- Rodriguez, M Alma
- Tsimberidou, Apostolia M
- Verstovsek, Srdan
- Younes, Anas
- Pro, Barbara
- Lee, Ming-Sheng
- Ayala, Ana
- McLaughlin, Peter
Producer: 20060413
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 24
Availability: No items available.
|
|
|
96.
|
FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors. [electronic resource] by
- Jardim, Denis L
- Wheler, Jennifer J
- Hess, Kenneth
- Tsimberidou, Apostolia M
- Zinner, Ralph
- Janku, Filip
- Subbiah, Vivek
- Naing, Aung
- Piha-Paul, Sarina A
- Westin, Shannon N
- Roy-Chowdhuri, Sinchita
- Meric-Bernstam, Funda
- Hong, David S
Producer: 20141014
In:
PloS one vol. 9
Availability: No items available.
|
|
|
97.
|
PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors. [electronic resource] by
- Janku, Filip
- Tsimberidou, Apostolia M
- Garrido-Laguna, Ignacio
- Wang, Xuemei
- Luthra, Rajyalakshmi
- Hong, David S
- Naing, Aung
- Falchook, Gerald S
- Moroney, John W
- Piha-Paul, Sarina A
- Wheler, Jennifer J
- Moulder, Stacy L
- Fu, Siqing
- Kurzrock, Razelle
Producer: 20110921
In:
Molecular cancer therapeutics vol. 10
Availability: No items available.
|
|
|
98.
|
Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway. [electronic resource] by
- Wheler, Jennifer J
- Moulder, Stacy L
- Naing, Aung
- Janku, Filip
- Piha-Paul, Sarina A
- Falchook, Gerald S
- Zinner, Ralph
- Tsimberidou, Apostolia M
- Fu, Siqing
- Hong, David S
- Atkins, Johnique T
- Yelensky, Roman
- Stephens, Philip J
- Kurzrock, Razelle
Producer: 20150123
In:
Oncotarget vol. 5
Availability: No items available.
|
|
|
99.
|
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. [electronic resource] by
- Janku, Filip
- Wheler, Jennifer J
- Westin, Shannon N
- Moulder, Stacy L
- Naing, Aung
- Tsimberidou, Apostolia M
- Fu, Siqing
- Falchook, Gerald S
- Hong, David S
- Garrido-Laguna, Ignacio
- Luthra, Rajyalakshmi
- Lee, J Jack
- Lu, Karen H
- Kurzrock, Razelle
Producer: 20120504
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 30
Availability: No items available.
|
|
|
100.
|
Advanced malignancies treated with a combination of the VEGF inhibitor bevacizumab, anti-EGFR antibody cetuximab, and the mTOR inhibitor temsirolimus. [electronic resource] by
- Liu, Xiaochun
- Kambrick, Susan
- Fu, Siqing
- Naing, Aung
- Subbiah, Vivek
- Blumenschein, George R
- Glisson, Bonnie S
- Kies, Merrill S
- Tsimberidou, Apostolia M
- Wheler, Jennifer J
- Zinner, Ralph G
- Hong, David S
- Kurzrock, Razelle
- Piha-Paul, Sarina A
Producer: 20180130
In:
Oncotarget vol. 7
Availability: No items available.
|